
1. Eur Respir J. 2016 Dec;48(6):1800-1802. doi: 10.1183/13993003.01208-2016. Epub
2016 Oct 6.

Shorter treatment for multidrug-resistant tuberculosis: the good, the bad and the
ugly.

van Altena R(1), Akkerman OW(1), Alffenaar JC(2), Kerstjens HA(1), Magis-Escurra 
C(3), Boeree MJ(3), van Soolingen D(4)(5), de Lange WC(1), Bolhuis MS(2),
Hoefsloot W(3), de Vries G(6)(7), van der Werf TS(8)(9).

Author information: 
(1)University of Groningen, University Medical Center Groningen, Dept of
Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands.
(2)University of Groningen, University Medical Center Groningen, Dept of Clinical
Pharmacy and Pharmacology, Groningen, The Netherlands.
(3)Tuberculosis Center, University Center for Chronic Diseases Dekkerswald,
Radboud Nijmegen University Medical Center, Nijmegen, The Netherlands.
(4)Tuberculosis Reference Laboratory, Centre for Infectious Diseases, National
Institute for Health and the Environment (RIVM), Bilthoven, The Netherlands.
(5)Depts of Medical Microbiology and Lung Disease, Radboud Nijmegen University
Medical Center, Nijmegen, The Netherlands.
(6)KNCV Tuberculosis Foundation, The Hague, The Netherlands.
(7)Centre for Infectious Diseases, National Institute of Public Health and the
Environment, Bilthoven, The Netherlands.
(8)University of Groningen, University Medical Center Groningen, Dept of
Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands
t.s.van.der.werf@umcg.nl.
(9)University of Groningen, University Medical Center Groningen, Dept of Internal
Medicine, Groningen, The Netherlands.

DOI: 10.1183/13993003.01208-2016 
PMID: 27824604  [Indexed for MEDLINE]

